Edgewise Therapeutics, Inc.
(EWTX - NASDAQ)
30,68 USD
📋 Profilo Aziendale

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.

|